Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Crinetics Pharmaceuticals Inc.
Exelixis
Cedars-Sinai Medical Center
Boston Scientific Corporation
Cook Group Incorporated
Hutchmed
University of Sao Paulo
Federation Francophone de Cancerologie Digestive
Instituto do Cancer do Estado de São Paulo
H. Lee Moffitt Cancer Center and Research Institute
Institut Bergonié
Xiangya Hospital of Central South University
Fudan University
Eli Lilly and Company
Hospices Civils de Lyon
Eli Lilly and Company
M.D. Anderson Cancer Center
Yale University
Novartis
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
University of Jena